SCCM Neuroscience Section/X
Nov 6, 2025, 07:08
Study Finds NOACs as Safe and Effective as Warfarin in CVST
SCCM Neuroscience Section posted on X:
”Use of new oral anticoagulants (NOACs) in cerebral venous sinus thrombosis (CVST) has similar efficacy and safety compared to warfarin treatment.
NOACs treatment may improve clinical prognosis in pts with CVST.”
Read the study here.
Title: Anticoagulant Therapy for Cerebral Venous Sinus Thrombosis: A Propensity Score Matching Study and Inverse Probability Weighting
Authors: Kai Liu, Mengmeng Zhang, Jiawei Zhao, Qinqin Dai, Yuan Gao, Shen Li, Lu Zhao, Yuming Xu, Bo Song
Stay informed with Hemostasis Today.
Anticoagulation
Bo Song
cerebral venous sinus thrombosis
CVST
Direct Oral Anticoagulants
DOACs
Health
Hematology
Hemostasis
Hemostasis Today
Jiawei Zhao
Kai Liu
Lu Zhao
Medicine
Mengmeng Zhang
New OralAnticoagulants
NOACs
Qinqin Dai
SCCM Neuroscience Section
Shen Li
thrombosis
Venous Thrombosis
Warfarin
Yuan Gao
Yuming Xu
-
Oct 9, 2026, 11:29Jigesha Dholakia: Supporting the Hemophilia Community Through the Unite Walk
-
Oct 9, 2026, 11:06Nobles Green: How siRNA Therapy Helps the Body Form Stronger Clots
-
Oct 9, 2026, 10:53Switching From Emicizumab to Denecimig in Hemophilia A – Rare Disease Advisor
-
Oct 9, 2026, 10:40What New U.S. Data Reveal About GT – Glanzmann’s Research Foundation
-
Oct 9, 2026, 10:32Anjali Pandey: The Morphologic Clues to MDS With del(5q)
-
Oct 9, 2026, 10:13Reza Shojaei: 5 Leadership Responsibilities for a Sustainable Plasma Ecosystem
-
Oct 9, 2026, 08:38Johannes Gratz: Perioperative Care in Factor VII Deficiency – Treating the Patient, Not the Number
-
Oct 9, 2026, 08:28Ghanim Fajish: Vascular Cells May Retain a Prothrombotic Memory of Oxidative Stress
-
Oct 9, 2026, 07:43Mehmet Cilingiroglu: The First Diagnosis of Coronary Thrombosis in a Living Patient